Asia Higher as Traders Pore Over China Figures
Asia-Pacific markets traded mostly higher Monday, as investors assessed China’s manufacturing and industrial profit data. In Japan, the Nikkei 225 plummeted 366.18 points, or 0.9%, to 39,565.80.
Asia report: Markets mixed as China factory activity contracts
Asia-Pacific markets traded mixed on Monday as investors assessed China's latest economic data, which showed an unexpected ...
Asian market mixed on Monday: Nikkei slips below 40,000, Hang Seng surges 1%
Asian markets were mixed as traders seemed cautious ahead of the monetary policy decisions from the US Fed and the European ...
Biogen Inc.: FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with ...
manilatimes19h
FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
LEQEMBI ® [ (lecanemab-irmb) 100 mg/mL injection for intravenous use] is indicated for the treatment of Alzheimer's disease (AD). Treatment with LEQEMBI should be initiated in patients with mild ...
Asia-Pacific markets mostly higher as investors parse China PMI and industrial profits data
Japan's Nikkei 225 futures pointed to a stronger open for the market. The futures contract in Chicago is currently at 40,260 and its counterpart in Osaka last traded at 40,480 compared to the index's ...